nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—HTR3A—migraine	0.688	1	CbGaD
Rocuronium—SLCO1A2—Verapamil—migraine	0.0779	0.362	CbGbCtD
Rocuronium—SLC22A1—Verapamil—migraine	0.0687	0.319	CbGbCtD
Rocuronium—CHRM2—Amitriptyline—migraine	0.0685	0.319	CbGbCtD
Rocuronium—HTR3A—cranial nerve—migraine	0.00354	0.178	CbGeAlD
Rocuronium—Myopathy—Propranolol—migraine	0.00258	0.0459	CcSEcCtD
Rocuronium—Electrocardiogram abnormal—Verapamil—migraine	0.00254	0.0452	CcSEcCtD
Rocuronium—Paralysis—Verapamil—migraine	0.0024	0.0426	CcSEcCtD
Rocuronium—HTR3A—nerve—migraine	0.00181	0.0914	CbGeAlD
Rocuronium—Respiratory failure—Verapamil—migraine	0.0017	0.0302	CcSEcCtD
Rocuronium—Paralysis—Gabapentin—migraine	0.00141	0.0251	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Propranolol—migraine	0.00136	0.0241	CcSEcCtD
Rocuronium—CHRND—cardiovascular system—migraine	0.00128	0.0647	CbGeAlD
Rocuronium—Electrocardiogram abnormal—Topiramate—migraine	0.00126	0.0224	CcSEcCtD
Rocuronium—Hiccups—Valproic Acid—migraine	0.00118	0.021	CcSEcCtD
Rocuronium—Apnoea—Gabapentin—migraine	0.00116	0.0205	CcSEcCtD
Rocuronium—Bronchospasm—Propranolol—migraine	0.00112	0.0199	CcSEcCtD
Rocuronium—Cardiovascular disorder—Gabapentin—migraine	0.00111	0.0198	CcSEcCtD
Rocuronium—Respiratory failure—Timolol—migraine	0.00107	0.019	CcSEcCtD
Rocuronium—Muscular weakness—Verapamil—migraine	0.00107	0.019	CcSEcCtD
Rocuronium—Bronchospasm—Verapamil—migraine	0.00103	0.0183	CcSEcCtD
Rocuronium—Arrhythmia—Amitriptyline—migraine	0.000998	0.0177	CcSEcCtD
Rocuronium—Respiratory failure—Gabapentin—migraine	0.000997	0.0177	CcSEcCtD
Rocuronium—Hiccups—Gabapentin—migraine	0.000979	0.0174	CcSEcCtD
Rocuronium—Cardiovascular disorder—Topiramate—migraine	0.000938	0.0167	CcSEcCtD
Rocuronium—HTR3A—trigeminal ganglion—migraine	0.00088	0.0443	CbGeAlD
Rocuronium—HTR3A—Ion channel transport—TRPM8—migraine	0.000873	0.0426	CbGpPWpGaD
Rocuronium—Hypertension—Amitriptyline—migraine	0.000839	0.0149	CcSEcCtD
Rocuronium—Shock—Amitriptyline—migraine	0.000781	0.0139	CcSEcCtD
Rocuronium—HTR3A—brainstem—migraine	0.000779	0.0392	CbGeAlD
Rocuronium—Tachycardia—Amitriptyline—migraine	0.000774	0.0138	CcSEcCtD
Rocuronium—Muscular weakness—Valproic Acid—migraine	0.000756	0.0134	CcSEcCtD
Rocuronium—Hypotension—Amitriptyline—migraine	0.000741	0.0132	CcSEcCtD
Rocuronium—CHRNA1—head—migraine	0.000726	0.0366	CbGeAlD
Rocuronium—CHRND—Neuronal System—KCNK18—migraine	0.000689	0.0336	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000682	0.0333	CbGpPWpGaD
Rocuronium—HTR3A—Ion channel transport—ATP1A2—migraine	0.000662	0.0323	CbGpPWpGaD
Rocuronium—HTR3A—Ion channel transport—ATP1A3—migraine	0.000662	0.0323	CbGpPWpGaD
Rocuronium—Asthma—Timolol—migraine	0.00066	0.0117	CcSEcCtD
Rocuronium—Bronchospasm—Timolol—migraine	0.000649	0.0115	CcSEcCtD
Rocuronium—Anaphylactic shock—Propranolol—migraine	0.000646	0.0115	CcSEcCtD
Rocuronium—Hypertension—Verapamil—migraine	0.000629	0.0112	CcSEcCtD
Rocuronium—Muscular weakness—Gabapentin—migraine	0.000627	0.0111	CcSEcCtD
Rocuronium—Asthma—Gabapentin—migraine	0.000614	0.0109	CcSEcCtD
Rocuronium—Bronchospasm—Gabapentin—migraine	0.000604	0.0107	CcSEcCtD
Rocuronium—CHRM2—Monoamine GPCRs—HTR1D—migraine	0.000604	0.0295	CbGpPWpGaD
Rocuronium—CHRNA2—head—migraine	0.000602	0.0303	CbGeAlD
Rocuronium—Anaphylactic shock—Verapamil—migraine	0.000594	0.0106	CcSEcCtD
Rocuronium—CHRNA1—Neuronal System—KCNK18—migraine	0.000586	0.0286	CbGpPWpGaD
Rocuronium—Shock—Verapamil—migraine	0.000585	0.0104	CcSEcCtD
Rocuronium—Tachycardia—Verapamil—migraine	0.00058	0.0103	CcSEcCtD
Rocuronium—CHRNA2—nervous system—migraine	0.000571	0.0288	CbGeAlD
Rocuronium—CHRM2—Monoamine GPCRs—HTR2B—migraine	0.000562	0.0274	CbGpPWpGaD
Rocuronium—Pruritus—Amitriptyline—migraine	0.000561	0.00998	CcSEcCtD
Rocuronium—CHRNB1—head—migraine	0.00056	0.0282	CbGeAlD
Rocuronium—CHRNA2—Neuronal System—KCNK18—migraine	0.000557	0.0272	CbGpPWpGaD
Rocuronium—Hypotension—Verapamil—migraine	0.000555	0.00987	CcSEcCtD
Rocuronium—CHRNA2—central nervous system—migraine	0.00055	0.0277	CbGeAlD
Rocuronium—CHRNA2—cerebellum—migraine	0.000537	0.0271	CbGeAlD
Rocuronium—CHRM2—cardiovascular system—migraine	0.000531	0.0267	CbGeAlD
Rocuronium—Arrhythmia—Valproic Acid—migraine	0.00053	0.00942	CcSEcCtD
Rocuronium—Muscular weakness—Topiramate—migraine	0.000527	0.00938	CcSEcCtD
Rocuronium—CHRNA1—brain—migraine	0.000526	0.0265	CbGeAlD
Rocuronium—Asthma—Topiramate—migraine	0.000517	0.00919	CcSEcCtD
Rocuronium—CHRM2—Amine ligand-binding receptors—HTR1D—migraine	0.000508	0.0248	CbGpPWpGaD
Rocuronium—Vomiting—Amitriptyline—migraine	0.000505	0.00897	CcSEcCtD
Rocuronium—Rash—Amitriptyline—migraine	0.0005	0.00889	CcSEcCtD
Rocuronium—CHRNB1—cerebellum—migraine	0.0005	0.0252	CbGeAlD
Rocuronium—Dermatitis—Amitriptyline—migraine	0.0005	0.00889	CcSEcCtD
Rocuronium—Hypersensitivity—Propranolol—migraine	0.000476	0.00846	CcSEcCtD
Rocuronium—CHRM2—Amine ligand-binding receptors—HTR2B—migraine	0.000472	0.0231	CbGpPWpGaD
Rocuronium—Arrhythmia—Timolol—migraine	0.000472	0.00839	CcSEcCtD
Rocuronium—Nausea—Amitriptyline—migraine	0.000471	0.00838	CcSEcCtD
Rocuronium—Hypertension—Valproic Acid—migraine	0.000446	0.00793	CcSEcCtD
Rocuronium—CHRND—Transmission across Chemical Synapses—CACNA1A—migraine	0.000439	0.0214	CbGpPWpGaD
Rocuronium—Hypersensitivity—Verapamil—migraine	0.000438	0.00778	CcSEcCtD
Rocuronium—CHRNA2—brain—migraine	0.000437	0.022	CbGeAlD
Rocuronium—HTR3A—head—migraine	0.00043	0.0217	CbGeAlD
Rocuronium—Anaphylactic shock—Valproic Acid—migraine	0.000421	0.00749	CcSEcCtD
Rocuronium—Pruritus—Verapamil—migraine	0.00042	0.00748	CcSEcCtD
Rocuronium—Tachycardia—Valproic Acid—migraine	0.000411	0.00731	CcSEcCtD
Rocuronium—Vomiting—Propranolol—migraine	0.000411	0.0073	CcSEcCtD
Rocuronium—HTR3A—nervous system—migraine	0.000408	0.0206	CbGeAlD
Rocuronium—Rash—Propranolol—migraine	0.000407	0.00724	CcSEcCtD
Rocuronium—Dermatitis—Propranolol—migraine	0.000407	0.00724	CcSEcCtD
Rocuronium—CHRNB1—brain—migraine	0.000406	0.0205	CbGeAlD
Rocuronium—Hypertension—Timolol—migraine	0.000397	0.00706	CcSEcCtD
Rocuronium—Hypotension—Valproic Acid—migraine	0.000394	0.007	CcSEcCtD
Rocuronium—HTR3A—central nervous system—migraine	0.000393	0.0198	CbGeAlD
Rocuronium—Nausea—Propranolol—migraine	0.000384	0.00682	CcSEcCtD
Rocuronium—Vomiting—Verapamil—migraine	0.000378	0.00672	CcSEcCtD
Rocuronium—Anaphylactic shock—Timolol—migraine	0.000375	0.00667	CcSEcCtD
Rocuronium—Rash—Verapamil—migraine	0.000375	0.00666	CcSEcCtD
Rocuronium—Dermatitis—Verapamil—migraine	0.000374	0.00666	CcSEcCtD
Rocuronium—CHRNA1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000373	0.0182	CbGpPWpGaD
Rocuronium—Hypertension—Gabapentin—migraine	0.00037	0.00657	CcSEcCtD
Rocuronium—Shock—Timolol—migraine	0.000369	0.00656	CcSEcCtD
Rocuronium—CHRM2—Monoamine GPCRs—HTR1B—migraine	0.000366	0.0179	CbGpPWpGaD
Rocuronium—CHRM2—head—migraine	0.000359	0.0181	CbGeAlD
Rocuronium—CHRNA2—Transmission across Chemical Synapses—CACNA1A—migraine	0.000355	0.0173	CbGpPWpGaD
Rocuronium—Nausea—Verapamil—migraine	0.000353	0.00628	CcSEcCtD
Rocuronium—SLC22A1—head—migraine	0.000353	0.0178	CbGeAlD
Rocuronium—CHRM2—Monoamine GPCRs—HTR1A—migraine	0.000352	0.0172	CbGpPWpGaD
Rocuronium—CHRNA1—ErbB2/ErbB3 signaling events—FOS—migraine	0.000352	0.0172	CbGpPWpGaD
Rocuronium—Hypotension—Timolol—migraine	0.000351	0.00623	CcSEcCtD
Rocuronium—Anaphylactic shock—Gabapentin—migraine	0.000349	0.00621	CcSEcCtD
Rocuronium—Shock—Gabapentin—migraine	0.000344	0.00611	CcSEcCtD
Rocuronium—Tachycardia—Gabapentin—migraine	0.000341	0.00606	CcSEcCtD
Rocuronium—CHRM2—nervous system—migraine	0.000341	0.0171	CbGeAlD
Rocuronium—CHRM2—Monoamine GPCRs—HTR2C—migraine	0.00034	0.0166	CbGpPWpGaD
Rocuronium—SLCO1A2—head—migraine	0.00034	0.0171	CbGeAlD
Rocuronium—CHRND—Neuronal System—CACNA1A—migraine	0.000336	0.0164	CbGpPWpGaD
Rocuronium—SLC22A1—nervous system—migraine	0.000335	0.0168	CbGeAlD
Rocuronium—CHRM2—central nervous system—migraine	0.000328	0.0165	CbGeAlD
Rocuronium—Hypotension—Gabapentin—migraine	0.000326	0.0058	CcSEcCtD
Rocuronium—SLCO1A2—nervous system—migraine	0.000322	0.0162	CbGeAlD
Rocuronium—SLC22A1—central nervous system—migraine	0.000322	0.0162	CbGeAlD
Rocuronium—HTR3A—brain—migraine	0.000312	0.0157	CbGeAlD
Rocuronium—Hypertension—Topiramate—migraine	0.000311	0.00553	CcSEcCtD
Rocuronium—Hypersensitivity—Valproic Acid—migraine	0.00031	0.00552	CcSEcCtD
Rocuronium—SLCO1A2—central nervous system—migraine	0.00031	0.0156	CbGeAlD
Rocuronium—CHRM2—Amine ligand-binding receptors—HTR1B—migraine	0.000308	0.015	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—TRPM8—migraine	0.000304	0.0148	CbGpPWpGaD
Rocuronium—SLCO1A2—cerebellum—migraine	0.000303	0.0153	CbGeAlD
Rocuronium—Pruritus—Valproic Acid—migraine	0.000298	0.0053	CcSEcCtD
Rocuronium—CHRM2—Monoamine GPCRs—HTR7—migraine	0.000298	0.0146	CbGpPWpGaD
Rocuronium—CHRM2—Amine ligand-binding receptors—HTR1A—migraine	0.000296	0.0145	CbGpPWpGaD
Rocuronium—Shock—Topiramate—migraine	0.000289	0.00514	CcSEcCtD
Rocuronium—Tachycardia—Topiramate—migraine	0.000287	0.0051	CcSEcCtD
Rocuronium—CHRNA1—Neuronal System—CACNA1A—migraine	0.000286	0.014	CbGpPWpGaD
Rocuronium—CHRM2—Amine ligand-binding receptors—HTR2C—migraine	0.000286	0.014	CbGpPWpGaD
Rocuronium—Hypersensitivity—Timolol—migraine	0.000276	0.00491	CcSEcCtD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—HTR1A—migraine	0.000276	0.0135	CbGpPWpGaD
Rocuronium—Hypotension—Topiramate—migraine	0.000275	0.00488	CcSEcCtD
Rocuronium—CHRNA2—Neuronal System—CACNA1A—migraine	0.000272	0.0133	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—TAC1—migraine	0.000271	0.0133	CbGpPWpGaD
Rocuronium—Vomiting—Valproic Acid—migraine	0.000268	0.00476	CcSEcCtD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—SLC6A4—migraine	0.000266	0.013	CbGpPWpGaD
Rocuronium—Rash—Valproic Acid—migraine	0.000266	0.00472	CcSEcCtD
Rocuronium—Dermatitis—Valproic Acid—migraine	0.000265	0.00472	CcSEcCtD
Rocuronium—Pruritus—Timolol—migraine	0.000265	0.00472	CcSEcCtD
Rocuronium—CHRM2—brain—migraine	0.00026	0.0131	CbGeAlD
Rocuronium—Hypersensitivity—Gabapentin—migraine	0.000257	0.00458	CcSEcCtD
Rocuronium—SLC22A1—brain—migraine	0.000256	0.0129	CbGeAlD
Rocuronium—SLC22A1—Neuronal System—KCNK18—migraine	0.000256	0.0125	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—ATP1A3—migraine	0.000251	0.0123	CbGpPWpGaD
Rocuronium—CHRM2—Amine ligand-binding receptors—HTR7—migraine	0.00025	0.0122	CbGpPWpGaD
Rocuronium—Nausea—Valproic Acid—migraine	0.00025	0.00445	CcSEcCtD
Rocuronium—Pruritus—Gabapentin—migraine	0.000247	0.00439	CcSEcCtD
Rocuronium—SLCO1A2—brain—migraine	0.000246	0.0124	CbGeAlD
Rocuronium—Vomiting—Timolol—migraine	0.000239	0.00424	CcSEcCtD
Rocuronium—Rash—Timolol—migraine	0.000237	0.00421	CcSEcCtD
Rocuronium—Dermatitis—Timolol—migraine	0.000236	0.0042	CcSEcCtD
Rocuronium—HTR3A—Transmembrane transport of small molecules—ATP1A2—migraine	0.00023	0.0112	CbGpPWpGaD
Rocuronium—HTR3A—Transmembrane transport of small molecules—ATP1A3—migraine	0.00023	0.0112	CbGpPWpGaD
Rocuronium—Nausea—Timolol—migraine	0.000223	0.00396	CcSEcCtD
Rocuronium—Vomiting—Gabapentin—migraine	0.000222	0.00395	CcSEcCtD
Rocuronium—Rash—Gabapentin—migraine	0.00022	0.00392	CcSEcCtD
Rocuronium—Dermatitis—Gabapentin—migraine	0.00022	0.00391	CcSEcCtD
Rocuronium—Hypersensitivity—Topiramate—migraine	0.000217	0.00385	CcSEcCtD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HTR3A—migraine	0.000214	0.0104	CbGpPWpGaD
Rocuronium—CHRM2—Monoamine GPCRs—HTR2A—migraine	0.000209	0.0102	CbGpPWpGaD
Rocuronium—Pruritus—Topiramate—migraine	0.000208	0.0037	CcSEcCtD
Rocuronium—Nausea—Gabapentin—migraine	0.000208	0.00369	CcSEcCtD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—BDNF—migraine	0.000193	0.00944	CbGpPWpGaD
Rocuronium—CHRM2—Calcium Regulation in the Cardiac Cell—CACNA1A—migraine	0.000189	0.00921	CbGpPWpGaD
Rocuronium—Vomiting—Topiramate—migraine	0.000187	0.00332	CcSEcCtD
Rocuronium—Rash—Topiramate—migraine	0.000185	0.00329	CcSEcCtD
Rocuronium—Dermatitis—Topiramate—migraine	0.000185	0.00329	CcSEcCtD
Rocuronium—CHRM2—Amine ligand-binding receptors—HTR2A—migraine	0.000175	0.00857	CbGpPWpGaD
Rocuronium—Nausea—Topiramate—migraine	0.000175	0.0031	CcSEcCtD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000168	0.00819	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—HTR2A—migraine	0.000163	0.00798	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—CACNA1A—migraine	0.000163	0.00796	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—EDNRA—migraine	0.000147	0.00718	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—HTR7—migraine	0.000132	0.00646	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ATP1A2—migraine	0.000127	0.00621	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ATP1A3—migraine	0.000127	0.00621	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—HTR1D—migraine	0.000126	0.00613	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—CACNA1A—migraine	0.000125	0.0061	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—TRPM8—migraine	0.000123	0.00598	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000117	0.00569	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000108	0.00529	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—HTR3A—migraine	0.000108	0.00528	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CALCRL—migraine	0.000105	0.00511	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—RAMP1—migraine	0.000105	0.00511	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HTR1A—migraine	0.000102	0.00496	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TAC1—migraine	0.0001	0.00489	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	9.99e-05	0.00488	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—SLC6A4—migraine	9.82e-05	0.0048	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	9.28e-05	0.00453	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ATP1A2—migraine	9.28e-05	0.00453	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ATP1A3—migraine	9.28e-05	0.00453	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Other—HTR2A—migraine	9.27e-05	0.00453	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—HTR3A—migraine	7.89e-05	0.00386	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—HTR1B—migraine	7.61e-05	0.00372	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR1D—migraine	7.6e-05	0.00371	CbGpPWpGaD
Rocuronium—CHRM2—G alpha (i) signalling events—HTR1A—migraine	7.33e-05	0.00358	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—BDNF—migraine	7.13e-05	0.00348	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR2B—migraine	7.07e-05	0.00345	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	7.06e-05	0.00345	CbGpPWpGaD
Rocuronium—HTR3A—SIDS Susceptibility Pathways—TNF—migraine	7.02e-05	0.00343	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.8e-05	0.00332	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	6.57e-05	0.00321	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	6.39e-05	0.00312	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	6.05e-05	0.00295	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—HTR2A—migraine	6.02e-05	0.00294	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—RAMP1—migraine	5.91e-05	0.00289	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CALCRL—migraine	5.91e-05	0.00289	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.82e-05	0.00284	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.75e-05	0.00281	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.74e-05	0.0028	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.74e-05	0.0028	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	5.62e-05	0.00275	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	5.47e-05	0.00267	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—RAMP1—migraine	5.37e-05	0.00262	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CALCRL—migraine	5.37e-05	0.00262	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.93e-05	0.00241	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR1B—migraine	4.61e-05	0.00225	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR1A—migraine	4.44e-05	0.00217	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—TAC1—migraine	4.37e-05	0.00213	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—NPS—migraine	4.37e-05	0.00213	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CACNA1A—migraine	4.3e-05	0.0021	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR1D—migraine	4.3e-05	0.0021	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR2C—migraine	4.28e-05	0.00209	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—EDNRA—migraine	4.17e-05	0.00203	CbGpPWpGaD
Rocuronium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	4.03e-05	0.00197	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CALCA—migraine	4.01e-05	0.00196	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR2B—migraine	4e-05	0.00195	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR1D—migraine	3.9e-05	0.00191	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR7—migraine	3.75e-05	0.00183	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR2B—migraine	3.63e-05	0.00177	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.45e-05	0.00169	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RAMP1—migraine	3.17e-05	0.00155	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CALCRL—migraine	3.17e-05	0.00155	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CACNA1A—migraine	3.14e-05	0.00154	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—HTR2A—migraine	2.63e-05	0.00128	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR1B—migraine	2.6e-05	0.00127	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TNF—migraine	2.59e-05	0.00126	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR1A—migraine	2.51e-05	0.00122	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—NPS—migraine	2.47e-05	0.00121	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—TAC1—migraine	2.47e-05	0.00121	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR2C—migraine	2.42e-05	0.00118	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR1B—migraine	2.36e-05	0.00115	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—EDNRA—migraine	2.35e-05	0.00115	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR1D—migraine	2.31e-05	0.00113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR1A—migraine	2.28e-05	0.00111	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CALCA—migraine	2.27e-05	0.00111	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—NPS—migraine	2.24e-05	0.00109	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—TAC1—migraine	2.24e-05	0.00109	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR2C—migraine	2.2e-05	0.00107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR2B—migraine	2.14e-05	0.00105	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EDNRA—migraine	2.14e-05	0.00104	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR7—migraine	2.12e-05	0.00104	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CALCA—migraine	2.06e-05	0.00101	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR7—migraine	1.93e-05	0.00094	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LRP1—migraine	1.89e-05	0.000922	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—HTR2A—migraine	1.48e-05	0.000725	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH4—migraine	1.45e-05	0.000707	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MTHFR—migraine	1.42e-05	0.000695	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR1B—migraine	1.4e-05	0.000682	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HTR2A—migraine	1.35e-05	0.000659	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR1A—migraine	1.34e-05	0.000657	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TAC1—migraine	1.32e-05	0.000647	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PGR—migraine	1.32e-05	0.000647	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NPS—migraine	1.32e-05	0.000647	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR2C—migraine	1.3e-05	0.000634	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EDNRA—migraine	1.26e-05	0.000617	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH3—migraine	1.23e-05	0.000601	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CALCA—migraine	1.22e-05	0.000594	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR7—migraine	1.14e-05	0.000555	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTHFR—migraine	1.04e-05	0.000508	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TGFBR2—migraine	9.79e-06	0.000478	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HTR2A—migraine	7.97e-06	0.000389	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ESR1—migraine	7.07e-06	0.000345	CbGpPWpGaD
